Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
Amicus Therapeutics, Inc. (FOLD)
Today's Latest Price: $15.68 USD
0.13 (0.84%)
Updated Jul 2 10:40am
Add FOLD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FOLD Stock Summary
- Of note is the ratio of Amicus Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 18.65% of US stocks have a lower such ratio.
- FOLD's price/sales ratio is 18.62; that's higher than the P/S ratio of 92.34% of US stocks.
- As for revenue growth, note that FOLD's revenue has grown 92.2% over the past 12 months; that beats the revenue growth of 93.83% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Amicus Therapeutics Inc, a group of peers worth examining would be STRO, BBIO, RMBS, CYTK, and ALBO.
- FOLD's SEC filings can be seen here. And to visit Amicus Therapeutics Inc's official web site, go to www.amicusrx.com.
FOLD Daily Price Range
FOLD 52-Week Price Range
FOLD Stock Price Chart Technical Analysis Charts
FOLD Price/Volume Stats
| Current price | $15.68 | 52-week high | $15.91 |
| Prev. close | $15.55 | 52-week low | $6.25 |
| Day low | $15.54 | Volume | 213,542 |
| Day high | $15.81 | Avg. volume | 3,380,861 |
| 50-day MA | $12.84 | Dividend yield | N/A |
| 200-day MA | $10.27 | Market Cap | 4.04B |
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
Loading social stream, please wait...